Publicacións en colaboración con investigadores/as de Universidad de Cantabria (35)

2024

  1. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank

    Clinical and experimental rheumatology, Vol. 42, Núm. 2, pp. 277-287

  2. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

    The Lancet Rheumatology, Vol. 6, Núm. 6, pp. e374-e383

2021

  1. Does social mobility influence health status? A systematic review

    Revista Espanola de Salud Publica, Vol. 95

  2. Improved short-term outcomes of kidney transplants in controlled donation after the circulatory determination of death with the use of normothermic regional perfusion

    American Journal of Transplantation, Vol. 21, Núm. 11, pp. 3618-3628

  3. Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome

    Scientific Reports, Vol. 11, Núm. 1

  4. Temperature-related effects on respiratory medical prescriptions in Spain

    Environmental Research, Vol. 202

2020

  1. Author Correction: Validating a breast cancer score in Spanish women. The MCC-Spain study (Scientific Reports, (2018), 8, 1, (3036), 10.1038/s41598-018-20832-0)

    Scientific Reports

  2. Corrigendum to “Lung cancer survival in never-smokers and exposure to residential radon: Results of the LCRINS study” [Canc. Lett. 487 (2020) 21-26] (Cancer Letters (2020) 487 (21-26), (S0304383520302846), (10.1016/j.canlet.2020.05.022))

    Cancer Letters

  3. Influence of MUC5B gene on antisynthetase syndrome

    Scientific Reports, Vol. 10, Núm. 1

  4. Levels of the novel endogenous antagonist of ghrelin receptor, liver-enriched antimicrobial peptide-2, in patients with rheumatoid arthritis

    Nutrients, Vol. 12, Núm. 4

  5. Lung cancer survival in never-smokers and exposure to residential radon: Results of the LCRINS study

    Cancer Letters, Vol. 487, pp. 21-26

  6. Reducing residual thrombotic risk in patients with peripheral artery disease: Impact of the COMPASS trial

    Drugs in Context, Vol. 9

  7. Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition

    Expert Review of Clinical Pharmacology, Vol. 13, Núm. 7, pp. 695-706

2019

  1. Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases

    Biochemical Pharmacology, Vol. 165, pp. 196-206

  2. Molecular relationships among obesity, inflammation and intervertebral disc degeneration: Are adipokines the common link?

    International Journal of Molecular Sciences, Vol. 20, Núm. 8

2018

  1. Adipokines and inflammation: is it a question of weight?

    British Journal of Pharmacology, Vol. 175, Núm. 10, pp. 1569-1579

  2. Biomechanics, obesity, and osteoarthritis. The role of adipokines: When the levee breaks

    Journal of Orthopaedic Research, Vol. 36, Núm. 2, pp. 594-604

  3. Hydraulic assessment of nanofluids based on mineral oil and natural ester in windings of power transformers

    Renewable Energy and Power Quality Journal, Vol. 1, Núm. 16, pp. 628-631

  4. Residential radon and cancer mortality in Galicia, Spain

    Science of the Total Environment, Vol. 610-611, pp. 1125-1132

  5. Validating a breast cancer score in Spanish women. The MCC-Spain study

    Scientific Reports, Vol. 8, Núm. 1